United Kingdom· GB-APID-3688011000001101
Orap 4mg tablets
A pimozide product containing pimozide, registered in United Kingdom by Eumedica Pharma Ltd. The same ATC class is registered in 11 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Pimozide is registered in 11 of 19 countries.
Countries holding a registration under ATC N05AG02 (pimozide), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 6 of them publish a price we can compare per daily dose
Pimozide · ATC N05AG02
11 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Italyprice
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of pimozide costs, country by country.
Normalised to the WHO defined daily dose (4 mg), the median price runs from $0.18 in France to $0.31 in Italy — a ×1.7 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Pimozide · price per daily dose (4 mg)
USD · FX 28 Sept 2026
- IT Italy$0.31
- FR France$0.18
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Pimozide
- Manufacturer
- Eumedica Pharma Ltd
- Country
- United Kingdom (GB)
- ATC code
- N05AG02
- ATC class
- Pimozide
- Defined daily dose
- 4 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5012674049419
- gtin05425025990184
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
317 interactions on record for pimozide.
Graded by severity as the source publishes them — 174 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pimozide · interactions on record
317 records
- 174 severe
- 140 moderate
- 3 minor
Most severe, free to view
- CimetidineA02BA01severe
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pimozide in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsOrap 4 mg, tablettenEU-Pharma B.V.
- NorwayOrapJanssen-Cilag
- CanadaPIMOZIDEAA PHARMA INC
- SpainORAP FUERTE 4 mg COMPRIMIDOSEumedica.
- FranceORAP 4 mg, compriméEUMEDICA PHARMACEUTICALS (ALLEMAGNE)
- United StatesPimozideANI Pharmaceuticals, Inc.
- GermanyOrapEumedica Pharmaceuticals Gmbh
- BelgiumOrap 1 mgEumedica
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Belgium · Orap, Orap Forte
- Germany · Orap, Orap Forte
- Denmark · Orap
- Spain · Orap, Orap Fuerte
- France · Orap
- Greece · Pirium
- Italy · Orap
- Luxembourg · Orap, Orap Forte
- Malta · Orap
- Netherlands · Orap
- Portugal · Orap Forte
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/31090b61-8f64-48e7-9fff-fbd351a7394e GET /v1/drugs/31090b61-8f64-48e7-9fff-fbd351a7394e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "3688011000001101",
"desc": "Orap 4mg tablets (Eumedica Pharma Ltd)",
"form": "Oral tablet",
"vpid": "42277511000001107",
"source": "dmd",
"vtm_id": "777199009",
"strength": "4 mg",
"substance": "Pimozide",
"ingredient": "Pimozide",
"supplier_code": "9552111000001104"
}See everything about pimozide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.